Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......

Brazil suspends Bharat Biotech's Covaxin clinical trials

Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with its partner there, the South American Country's......

Bharat Biotech has two more Covid vaccines in pipeline

Today, the firm has delivered over four billion doses of vaccines and has over 140 patents under its belt. The company has in its portfolio over 16 vaccines and four bio-therapeutics, including......

Bharat Biotech making single-dose intranasal Covid vaccine

Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech  ......

What's behind Bharat Biotech's Zika 'hype'?

Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......

Budget 2025: Grassroot Level Implementation Is Necessary

Budget 2025 represents a crucial step towards empowering our youth, nurturing a sustainable startup ecosystem, and establishing India as a global leader in agriculture, medical tourism, and......

India set to be global clinical trials hub

India is emerging as a major hub for global clinical trials and this new sector is poised to generate more revenue than the information technology industry by 2010, an industry leader has......